Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 11, 2021

SELL
$10.34 - $13.77 $10.3 Million - $13.8 Million
-1,000,000 Closed
0 $0
Q3 2020

Nov 13, 2020

SELL
$11.73 - $16.25 $10.3 Million - $14.2 Million
-875,000 Reduced 46.67%
1,000,000 $11.9 Million
Q2 2020

Aug 14, 2020

SELL
$13.68 - $20.46 $5.81 Million - $8.7 Million
-425,000 Reduced 18.48%
1,875,000 $30.1 Million
Q1 2020

May 14, 2020

BUY
$14.83 - $26.72 $741,500 - $1.34 Million
50,000 Added 2.22%
2,300,000 $35.7 Million
Q4 2019

Feb 13, 2020

BUY
$9.77 - $24.6 $7.33 Million - $18.5 Million
750,000 Added 50.0%
2,250,000 $55.4 Million
Q3 2019

Nov 14, 2019

SELL
$10.17 - $13.86 $1.53 Million - $2.08 Million
-150,000 Reduced 9.09%
1,500,000 $15.5 Million
Q2 2019

Aug 09, 2019

SELL
$11.43 - $15.12 $1.14 Million - $1.51 Million
-100,000 Reduced 5.71%
1,650,000 $20.7 Million
Q1 2019

May 10, 2019

BUY
$5.98 - $13.98 $10.5 Million - $24.5 Million
1,750,000 New
1,750,000 $21.7 Million

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Artal Group S.A. Portfolio

Follow Artal Group S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

News

Stay updated on Artal Group S.A. with notifications on news.